Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Active, not recruiting · NCT02101775 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | Adnexal Diseases, Brenner tumor, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Urogenital Diseases, Urogenital Neoplasms, connective tissue neoplasm, endocrine system disorder, epithelial neoplasm, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, fibroepithelial neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian Brenner tumor, ovarian cancer, ovarian carcinosarcoma, ovarian clear cell cystadenocarcinoma, ovarian disorder, ovarian endometrioid adenocarcinoma, ovarian mucinous cystadenocarcinoma, ovarian seromucinous carcinoma, ovarian serous cystadenocarcinoma, ovarian serous surface papillary adenocarcinoma, undifferentiated ovarian carcinoma | Active, not recruiting | Phase 2 | 2026-09-10 | NCT02101775 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BCCA-Cancer Centre for the Southern Interior | Kelowna | Canada | 8 |
| BCCA-Vancouver Cancer Centre | Vancouver | Canada | 35 |
| CHUM - Centre Hospitalier de l'Universite de Montreal | Montreal | Canada | 35 |
| City of Hope Comprehensive Cancer Center | Duarte | United States | 263 |
| City of Hope South Pasadena | South Pasadena | United States | 77 |
| Decatur Memorial Hospital | Decatur | United States | 303 |
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| Indiana University/Melvin and Bren Simon Cancer Center | Indianapolis | United States | 138 |
| London Regional Cancer Program | London | Canada | 40 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |
| National University Hospital Singapore | Singapore | Singapore | 14 |
| Ottawa Hospital and Cancer Center-General Campus | Ottawa | Canada | 35 |
| University Health Network Princess Margaret Cancer Center P2C | Toronto | Canada | 2 |
| University Health Network-Princess Margaret Hospital | Toronto | Canada | 88 |
| University of Chicago Comprehensive Cancer Center | Chicago | United States | 273 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |